[Which is the role of the angiotensin II receptor blockers (ARBs) for the treatment of heart failure? Do we work based on evidence/recommendations or pharmaceutical industry pressure?].

de la Fuente Cid, R; Varela Román, A

[Which is the role of the angiotensin II receptor blockers (ARBs) for the treatment of heart failure? Do we work based on evidence/recommendations or pharmaceutical industry pressure?]. / ¿Qué papel ocupan los ARA-II en el tratamiento de la insuficiencia cardiaca? ¿Actuamos por evidencias/recomendaciones o por la presión de la industria farmacéutica?

de la Fuente Cid, R; Varela Román, A.

Affiliation

de la Fuente Cid R; Complexo Hospitalario Universitario, Santiago de Compostela, A Coruña, Spain. ramondfc@yahoo.es

An Med Interna ; 24(12): 607-9, 2007 Dec.

Article in Es | MEDLINE | ID: mdl-18279002

Subject(s)

Angiotensin II Type 1 Receptor Blockers/therapeutic use; Heart Failure/drug therapy; Drug Industry; Evidence-Based Medicine; Humans; Practice Guidelines as Topic

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Angiotensin II Type 1 Receptor Blockers / Heart Failure Type of study: Guideline / Prognostic_studies / Risk_factors_studies Limits: Humans Language: Es Journal: An Med Interna Journal subject: MEDICINA INTERNA Year: 2007 Document type: Article Affiliation country: Spain Country of publication: Spain

Search on Google

Add to My VHL

XML

PubMed Links